Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer.

Kanyong P, Rawlinson S, Davis J.

J Cancer. 2016 Feb 10;7(5):523-31. doi: 10.7150/jca.13821. eCollection 2016. Review.

2.

Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.

Alinezhad S, Väänänen RM, Ochoa NT, Vertosick EA, Bjartell A, Boström PJ, Taimen P, Pettersson K.

BMC Urol. 2016 Feb 29;16:10. doi: 10.1186/s12894-016-0128-8.

3.

A rare presentation of metastasis of prostate adenocarcinoma to the stomach and rectum.

Soe AM, Bordia S, Xiao PQ, Lopez-Morra H, Tejada J, Atluri S, Krishnaiah M.

J Gastric Cancer. 2014 Dec;14(4):271-4. doi: 10.5230/jgc.2014.14.4.271. Epub 2014 Dec 26.

4.

p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers.

Kalantari MR, Anvari K, Jabbari H, Tabrizi FV.

Iran J Basic Med Sci. 2014 Jul;17(7):497-501.

5.

Prevalence of circulating tumor cells in localized prostate cancer.

Khurana KK, Grane R, Borden EC, Klein EA.

Curr Urol. 2013 Nov;7(2):65-9. doi: 10.1159/000356251. Epub 2013 Oct 30.

6.

Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.

Galletti G, Portella L, Tagawa ST, Kirby BJ, Giannakakou P, Nanus DM.

Mol Diagn Ther. 2014 Aug;18(4):389-402. doi: 10.1007/s40291-014-0101-8.

7.

Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.

Sequeiros T, García M, Montes M, Oliván M, Rigau M, Colás E, de Torres I, Morote J, Reventós J, Doll A.

Biomed Res Int. 2013;2013:283635. doi: 10.1155/2013/283635. Epub 2013 Nov 25. Review.

8.

The expressions of AMACR and iNOS in prostate adenocarcinomas.

Ozgur T, Atik E, Hakverdi S, Yaldiz M.

Pak J Med Sci. 2013 Apr;29(2):610-3.

9.

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications.

Murray NP, Reyes E, Badínez L, Orellana N, Fuentealba C, Olivares R, Porcell J, Dueñas R.

J Oncol. 2013;2013:165014. doi: 10.1155/2013/165014. Epub 2013 Apr 17.

10.

Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.

Young A, Palanisamy N, Siddiqui J, Wood DP, Wei JT, Chinnaiyan AM, Kunju LP, Tomlins SA.

Am J Clin Pathol. 2012 Nov;138(5):685-96. doi: 10.1309/AJCPU7PPWUPYG8OH.

11.

Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.

Tomlins SA, Palanisamy N, Siddiqui J, Chinnaiyan AM, Kunju LP.

Arch Pathol Lab Med. 2012 Aug;136(8):935-46. doi: 10.5858/arpa.2011-0424-OA.

12.

Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.

Hechtman JF, Xiao GQ, Unger PD, Kinoshita Y, Godbold JH, Burstein DE.

Appl Immunohistochem Mol Morphol. 2012 Jul;20(4):344-9. doi: 10.1097/PAI.0b013e31824013ba.

13.

Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.

Price AJ, Allen NE, Appleby PN, Crowe FL, Jenab M, Rinaldi S, Slimani N, Kaaks R, Rohrmann S, Boeing H, Pischon T, Benetou V, Naska A, Trichopoulou A, Palli D, Sieri S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Donate I, González CA, Sánchez MJ, Chirlaque MD, Ardanaz E, Larrañaga N, Khaw KT, Rodwell S, Gallo V, Michaud DS, Riboli E, Key TJ.

Am J Clin Nutr. 2010 Jun;91(6):1769-76. doi: 10.3945/ajcn.2009.28831. Epub 2010 Apr 28.

14.

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.

Honma I, Torigoe T, Hirohashi Y, Kitamura H, Sato E, Masumori N, Tamura Y, Tsukamoto T, Sato N.

J Transl Med. 2009 Dec 9;7:103. doi: 10.1186/1479-5876-7-103.

15.

Cancer of unknown primary finally revealed to be a metastatic prostate cancer: a case report.

Cho JY, Shim EJ, Kim IS, Nam EM, Choi MY, Lee KE, Mun YC, Seoung CM, Lee SN, Song DE, Han WS.

Cancer Res Treat. 2009 Mar;41(1):45-9. doi: 10.4143/crt.2009.41.1.45. Epub 2009 Mar 31.

16.

Diagnosis of adenocarcinoma in prostate needle biopsy tissue.

Humphrey PA.

J Clin Pathol. 2007 Jan;60(1):35-42. Review.

17.

Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Stewart J, Fleshner N, Cole H, Sweet J.

J Clin Pathol. 2007 Jul;60(7):773-80. Epub 2006 Aug 17.

Supplemental Content

Support Center